Supplementary Figure 2S from A Randomized Phase II/III Study of Naptumomab Estafenatox + IFNα Versus IFNα in Renal Cell Carcinoma: Final Analysis with Baseline Biomarker Subgroup and Trend Analysis
openalex
关键词
Renal Cell Carcinoma
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要